Central Nervous System Depressants
10
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
30%
3 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Natural History of Depression, Bipolar Disorder and Suicide Risk
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
Relative Bioavailability of LY03010 Compared to Listed Drug
Opioid-free Anesthesia in Laparoscopic Cholecystectomies
Lidocaine and Magnesium and Ketamine in Gynecological Surgery
Opioid-free Anesthesia With a Mixture of Dexmedetomidine-lidocaine-ketamine
Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine
Alcohol, Behavior, and Brain Imaging
Comparison Between Natural Sleep Endoscopy and Drug-induced Sleep Endoscopy in Patients With Obstructive Sleep Apnea